Order Article Reprints

Geyer T, Kazmierczak PM, Steffen IG, Malfertheiner P, Peynircioglu B, Loewe C, Delden Ov, Vandecaveye V, Gebauer B, Pech M, et al. Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial. Biomedicines. 2022; 10(5):1156. https://doi.org/10.3390/biomedicines10051156

Geyer, Thomas, Philipp M. Kazmierczak, Ingo G. Steffen, Peter Malfertheiner, Bora Peynircioglu, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Bernhard Gebauer, Maciej Pech, and et al. 2022. "Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial" Biomedicines 10, no. 5: 1156. https://doi.org/10.3390/biomedicines10051156

Geyer, T., Kazmierczak, P. M., Steffen, I. G., Malfertheiner, P., Peynircioglu, B., Loewe, C., Delden, O. v., Vandecaveye, V., Gebauer, B., Pech, M., Sengel, C., Bargellini, I., Iezzi, R., Benito, A., Zech, C. J., Gasbarrini, A., Schütte, K., Ricke, J., & Seidensticker, M. (2022). Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial. Biomedicines, 10(5), 1156. https://doi.org/10.3390/biomedicines10051156